Back to results
US 12,329,741 B2Granted
HBV inhibitor and its use
AssigneeXi'an Xintong Pharmaceutical Research Co., Ltd.
InventorsWeibo Guo, Dengke Zhang, Weili Jin, Mingzhe Ji, Yanxia Zhang
Life of this patent
Estimating the term…
Abstract
The present invention provides anti-HBV compounds, pharmaceutically acceptable compounds or stereoisomers thereof, and preparation methods and uses for treating, eradicating or inhibiting HBV infection or for alleviating liver injury caused by HBV infection, and so on.
Claims10
A compound, pharmaceutically acceptable salt or stereoisomer thereof, the compound being:
A compound, pharmaceutically acceptable salt or stereoisomer thereof, the compound is selected from:
- Comp-
- ound
- No.
- Structural Formula
- 29
- 30
- 31
- 32
- 33
- 34
- 35
- 36
- 37
- 38
- 39
- 40
- 41
- 44
- 45
- 85
- 86
18 more elements
Dependencies are inferred from the claim text.